menu search

MNKD / MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript

MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
MannKind Corporation (NASDAQ:MNKD ) Q3 2022 Results Conference Call November 8, 2022 9:00 AM ET Company Participants Michael Castagna - Chief Executive Officer Steven Binder - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Gregory Renza - RBC Capital Markets Robert Hazlett - BTIG Operator Good morning. And welcome to the MannKind Corporation Third Quarter 2022 Earnings Call. Read More
Posted: Nov 8 2022, 15:14
Author Name: Seeking Alpha
Views: 110858

MNKD News  

MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023

By GlobeNewsWire
October 31, 2023

MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2023 third quarter more_horizontal

Tyvaso DPI Is Breathing New Life Into MannKind's Balance Sheet (Rating Upgrade)

By Seeking Alpha
October 18, 2023

Tyvaso DPI Is Breathing New Life Into MannKind's Balance Sheet (Rating Upgrade)

Tyvaso DPI, a collaboration with United Therapeutics, diversifies MannKind's revenue streams and leverages its proprietary Technosphere technology, bo more_horizontal

Why MannKind Stock Soared 19% Higher on Tuesday

By The Motley Fool
August 8, 2023

Why MannKind Stock Soared 19% Higher on Tuesday

There's nothing like an estimate-topping quarter to put some pep in a company. A big jump in royalty revenue was particularly notable. more_horizontal

MannKind Corporation (MNKD) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 8, 2023

MannKind Corporation (MNKD) Q2 2023 Earnings Call Transcript

MannKind Corporation (NASDAQ:MNKD ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Michael Castagna - Chief Executive more_horizontal

Here's What Key Metrics Tell Us About MannKind (MNKD) Q2 Earnings

By Zacks Investment Research
August 7, 2023

Here's What Key Metrics Tell Us About MannKind (MNKD) Q2 Earnings

While the top- and bottom-line numbers for MannKind (MNKD) give a sense of how the business performed in the quarter ended June 2023, it could be wort more_horizontal

MannKind (MNKD) Reports Break-Even Earnings for Q2

By Zacks Investment Research
August 7, 2023

MannKind (MNKD) Reports Break-Even Earnings for Q2

MannKind (MNKD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.1 more_horizontal

MannKind shares fall after fire that may delay clinical trial

By Market Watch
July 3, 2023

MannKind shares fall after fire that may delay clinical trial

Shares of MannKind Corp. MNKD, +2.78% fell 1.5% premarket on Monday after the biopharma company said a fire at a German manufacturing facility may del more_horizontal

Why Shares of MannKind Are Up Wednesday

By The Motley Fool
May 10, 2023

Why Shares of MannKind Are Up Wednesday

MannKind had a big jump in revenue year over year. The company has benefitted from its collaboration agreement with United Therapeutics. more_horizontal


Search within

Pages Search Results: